Press release
Global Actinic Keratosis Market Projected to Surpass $10.58 Billion by 2029 with 5.8% Annual Growth
Actinic Keratosis
The rising incidence of severe sunburns is expected to accelerate the growth of the actinic keratosis market. Severe sunburns result from excessive exposure to ultraviolet (UV) radiation, causing redness, pain, swelling, and sometimes blistering. Factors such as prolonged UV exposure, inadequate sun protection, increased outdoor activities during peak UV hours, and climate change-induced temperature rises contribute to sunburn cases. Sunburns can lead to actinic keratosis by causing DNA damage in skin cells through UV radiation, leading to mutations that interfere with normal cell function and contribute to the formation of precancerous lesions, especially after repeated sun exposure. For instance, in May 2024, Melanoma Focus, a UK-based charity, reported that in 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 infants under one year old. Additionally, 66% of UK adults aged 16-65 recalled experiencing sunburn during childhood, with 65% suffering from severe sunburn with blisters at least once. This number increased to 77% for individuals with light, pale, or white skin. Therefore, the rising incidence of severe sunburns is driving the actinic keratosis market.
Get Your Actinic Keratosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report
How will the growth rate of the actinic keratosis market shape industry trends by 2034?
The actinic keratosis market has seen consistent growth over the years. It is projected to grow from $7.95 billion in 2024 to $8.44 billion in 2025, at a CAGR of 6.1%. The key factors behind this historical growth include increased exposure to UV radiation, an aging population, greater awareness of skin cancer, a rising prevalence of actinic keratosis, improved healthcare infrastructure, higher disposable incomes, government initiatives, and an increased focus on preventive skincare.
The actinic keratosis market size is anticipated to witness substantial growth in the upcoming years. By 2029, it is projected to reach $10.58 billion, growing at a compound annual growth rate (CAGR) of 7.4%. The expected growth is fueled by the emergence of advanced therapies, improvements in AI-powered diagnostic tools, a rising adoption of combination treatments, increasing demand for non-invasive procedures, the growing use of teledermatology, broader applications of photodynamic therapy, increased awareness of cosmetic outcomes, the development of targeted biologic treatments, rising healthcare investment in emerging markets, and a stronger focus on early detection and prevention. Major trends during this period include AI-driven diagnostic tools, machine learning for lesion analysis, advancements in photodynamic therapy, wearable UV monitoring devices, nanotechnology-based drug delivery systems, 3D imaging for personalized treatments, portable home-based phototherapy devices, biosensors for early detection, automated lesion classification software, and hydrogel-based therapeutic systems.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp
What trends are poised to drive the future success of the actinic keratosis market?
In the actinic keratosis market, major players are focusing on topical ointments to treat precancerous lesions and improve patient compliance with shorter treatment durations. A key example is Klisyri (tirbanibulin), developed by Almirall SA, a Spain-based biopharmaceutical company. In June 2024, Klisyri received FDA approval for its expanded use on up to 100 cm2 of affected skin, offering a more targeted treatment for actinic keratosis on the face or scalp.
Which primary segments of the actinic keratosis market are driving growth and industry transformations?
The actinic keratosis market covered in this report is segmented -
1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types
2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users
Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids
2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision
3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy
4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077
Which geographical regions are pioneering growth in the actinic keratosis market?
North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the actinic keratosis market landscape?
Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp
What Is Covered In The Actinic Keratosis Global Market Report?
•Market Size Forecast: Examine the actinic keratosis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the actinic keratosis market for a structured understanding.
•Key Players Overview: Analyze major players in the actinic keratosis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the actinic keratosis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the actinic keratosis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the actinic keratosis market.
•Industry Challenges: Identify potential risks and obstacles affecting the actinic keratosis market.
•Competitive Landscape: Review strategic developments in the actinic keratosis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Actinic Keratosis Market Projected to Surpass $10.58 Billion by 2029 with 5.8% Annual Growth here
News-ID: 3934412 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Actinic
Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction
Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth.
Over…
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, you…
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on to…
Actinic Keratosis Treatment Market To Increase at Steady Growth Rate
Actinic keratosis (AK) is a form of skin cancer and it is also known as solar keratosis. This indication tends to affect the sun-exposed parts of the skin such as face, bald scalp, lips, and the back of the hands among others. As a result of the exposure, the skin tends to become rough, uneven and display a warty look. Approximately, 10% of the exposed areas tend to develop squamous…
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study “ United States Actinic Keratosis Treatment Market Report 2016 ”, is a comparative analysis of the global market.
Notes:
Sales, means the sales volume of Actinic Keratosis Treatment
Revenue, means the sales value of Actinic Keratosis Treatment
This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and market…
Actinic Launches Ecommerce Fraud Checking Service with The 3rd Man
West Byfleet, Surrey – 3 June 2009 – With research showing consumers increasingly worried about card security when shopping online, Actinic (www.actinic.co.uk), the UK expert in ecommerce for small and medium businesses, has responded to the challenge with a major enhancement to its Actinic Payments service for combating card-not-present (CNP) fraud. Actinic Payments’ merchants now have seamless access to the anti-fraud, card verification service from The 3rd Man for no…
